Jubilant Cadista Pharmaceuticals is voluntarily recalling 4,680 bottles of Valsartan (320 mg) tablets, a prescription medication used to treat high blood pressure and heart failure. The recall was initiated because certain batches were manufactured with a larger size grade of the inactive ingredient Crospovidone than is required by the product's specifications. This defect affects approximately 2,328 bottles of lot VR417065A and 2,352 bottles of lot VR417066A, which were distributed to wholesalers and pharmacies in several U.S. states.
The use of an incorrect size grade of an inactive ingredient can potentially affect how the tablet dissolves or is absorbed by the body. While the risk level is classified as low, the product does not meet its approved quality standards.
Contact healthcare provider and return product.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.